| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.3M | -36.8% |
| SG&A Expense | $12.3M | +1.7% |
| Operating Income | -$36.5M | +27.6% |
| Pre-tax Income | -$35.4M | +30.2% |
| Income Tax | $0 | — |
| Net Income | -$35.4M | +30.2% |
| EPS (Basic) | -$1.37 | +53.6% |
| EPS (Diluted) | -$1.37 | +53.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.8M | -61.7% |
| Current Assets | $120.7M | +67.2% |
| Total Assets | $126.4M | +60.7% |
| Current Liabilities | $10.7M | +21.0% |
| Total Liabilities | $15.5M | +8.8% |
| Stockholders' Equity | $110.9M | +72.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.6M | +34.5% |
| Capital Expenditures | $100K | -70.0% |
| Investing Cash Flow | -$91.0M | -476.3% |
| Financing Cash Flow | $75.3M | +278.5% |
| Free Cash Flow | -$27.7M | +34.8% |